In fact, the downregulation of cell cycle G1 to S-phase transition genes such as cyclin kinase inhibitors may promote further proliferation, rather than inhibition, in MYCN-amplified RB1-proficient retinoblastoma. The gene discussed is RB1; the disease is retinoblastoma.